Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Citi
Chinese Patent Office
Johnson and Johnson
US Department of Justice
Federal Trade Commission
Harvard Business School
QuintilesIMS
Accenture
Cipla

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,510,353

« Back to Dashboard

Summary for Patent: 5,510,353
Title: Certain aminoguanidine compounds, pharmaceutical compositions containing them and their use in treating gastrointestinal motility disorders and disorders associated with cephalic pain
Abstract:Compounds of formula wherein A is derived from optionally substituted benzothiophene, indole, 4-aza-and 7-aza-benzothiophene or-indole, A bearing in position 5 hydrogen, halogen, optionally substituted alkyl, hydroxy, nitro, amino, alkylamino, acylamino, alkoxycarbonyl, sulfamoyl, cyano, trimethylsilyl, carboxy, carbamoyl, phosphate, oxycarbamoyl, heterocyclic radical or ether or ester group, X-Y is --CR.sub.8 .dbd.N-- or CH(R.sub.8)--NH-- wherein R.sub.8 is -H or alkyl and attached at position 3 of A, and B is a heterocyclic radical or a residue ##STR1## wherein R.sub.10 is H, optionally substituted alkyl, cycloalkyl, aryl, adamantyl, acyl or carbamoyl and X.sub.2 is alkylthio or NR.sub.3 R.sub.10 wherein R.sub.3 is H or alkyl or R.sub.3 and R.sub.10 together with the nitrogen atom to which they are attached form a heterocyclic radical, in free form or in salt form, have pharmacological activity, e.g. for treating gastrointestinal disorders.
Inventor(s): Giger; Rudolf K. A. (Muttenz, CH), Mattes; Henri (Brunstadt, FR)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:08/370,038
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,510,353

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,510,353

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9106179Mar 22, 1991
United Kingdom9107927Apr 15, 1991

International Patents Family Members for US Patent 5,510,353

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 170838 ➤ Try a Free Trial
Australia 1309292 ➤ Try a Free Trial
Australia 651442 ➤ Try a Free Trial
Brazil 1100237 ➤ Try a Free Trial
Canada 2063671 ➤ Try a Free Trial
Czechoslovakia 9200858 ➤ Try a Free Trial
Czech Republic 284339 ➤ Try a Free Trial
Germany 69226894 ➤ Try a Free Trial
Denmark 0505322 ➤ Try a Free Trial
European Patent Office 0505322 ➤ Try a Free Trial C00505322/01 Switzerland ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Dow
McKesson
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Medtronic
Fuji
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot